Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vigil

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Breast (Edinburgh, Scotland)|August 14, 2010
Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancerHenry L Gómez, Joseph A Pinto, Mivael Olivera, et al.
Current Hematologic Malignancy Reports|October 10, 2015
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a ReassessmentA A Gru, B H Haverkos, A G Freud, et al.
Blood Advances|March 20, 2024
Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trialsPau Montesinos, Amir T Fathi, Stéphane de Botton, et al.
International Journal of Cancer|December 15, 2010
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytomaS Tariq Mahmood, Samuel Agresta, Carlos E Vigil, et al.
Leukemia Research|March 5, 2016
A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemiaElizabeth A Griffiths, William E Brady, Wei Tan, et al.
Leukemia Research|May 23, 2013
Myelodysplastic syndromes and autoimmune diseases--case series and review of literatureOmar Al Ustwani, Laurie A Ford, Sheila J N Sait, et al.
Hipertension Y Riesgo Vascular|March 2, 2025
Prevalence of prehypertension and high normal blood pressure in Latin America: A systematic review with meta-analysisV J Vera-Ponce, J A Loayza-Castro, F E Zuzunaga-Montoya, et al.
Leukemia Research|September 10, 2013
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of ageCarlos E Vigil, Wei Tan, George Deeb, et al.
Hematology/Oncology and Stem Cell Therapy|October 5, 2010
Prognostic effect of hormone receptor status in early HER2 positive breast cancer patientsHenry L Gómez, Carlos A Castañeda, Carlos E Vigil, et al.
Clinical Breast Cancer|August 14, 2010
Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital databaseCarlos S Vallejos, Henry L Gómez, Wilder R Cruz, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Breast (Edinburgh, Scotland)|August 14, 2010
Topoisomerase II-α as a predictive factor of response to therapy with anthracyclines in locally advanced breast cancerHenry L Gómez, Joseph A Pinto, Mivael Olivera, et al.
Current Hematologic Malignancy Reports|October 10, 2015
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a ReassessmentA A Gru, B H Haverkos, A G Freud, et al.
Blood Advances|March 20, 2024
Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trialsPau Montesinos, Amir T Fathi, Stéphane de Botton, et al.
International Journal of Cancer|December 15, 2010
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytomaS Tariq Mahmood, Samuel Agresta, Carlos E Vigil, et al.
Leukemia Research|March 5, 2016
A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemiaElizabeth A Griffiths, William E Brady, Wei Tan, et al.
Leukemia Research|May 23, 2013
Myelodysplastic syndromes and autoimmune diseases--case series and review of literatureOmar Al Ustwani, Laurie A Ford, Sheila J N Sait, et al.
Hipertension Y Riesgo Vascular|March 2, 2025
Prevalence of prehypertension and high normal blood pressure in Latin America: A systematic review with meta-analysisV J Vera-Ponce, J A Loayza-Castro, F E Zuzunaga-Montoya, et al.
Leukemia Research|September 10, 2013
Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of ageCarlos E Vigil, Wei Tan, George Deeb, et al.
Hematology/Oncology and Stem Cell Therapy|October 5, 2010
Prognostic effect of hormone receptor status in early HER2 positive breast cancer patientsHenry L Gómez, Carlos A Castañeda, Carlos E Vigil, et al.
Clinical Breast Cancer|August 14, 2010
Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital databaseCarlos S Vallejos, Henry L Gómez, Wilder R Cruz, et al.
Pageof 6